secwatch.observer — SEC 8-K summary
======================================

Issuer:     InspireMD, Inc. (NSPR)
CIK:        0001433607
Form:       8-K
Filed at:   2024-05-14T23:59:59+00:00
Accession:  0001493152-24-019080
Event type: earnings
Sentiment:  neutral
Materiality: 0.65
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

InspireMD Q1 revenue up 22% to $1.51M; net loss widens to $7.0M ($0.21/sh)
--------------------------------------------------------------------------

- Revenue $1.51M (+22% YoY); stent units sold 2,553 (+25.6% YoY).
- Net loss $7.03M ($0.21/sh) vs $4.26M ($0.53/sh) in Q1 2023; operating expenses $7.71M (+62%).
- Gross margin fell to 19.4% from 30.1% due to higher training costs.
- Cash $34.0M; one-year C-GUARDIANS results to be presented at LINC 2024.
- CE Mark recertified under MDR; Pete Ligotti appointed EVP/GM North America.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1433607/000149315224019080/0001493152-24-019080-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1433607/000149315224019080/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-019080

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer